Yamamoto K, Ikeda U, Fukazawa H, Shimada K
Department of Cardiology, Jichi Medical School, Tochigi, Japan.
Am J Cardiol. 1996 Mar 1;77(7):528-30. doi: 10.1016/s0002-9149(97)89351-4.
Aspirin 330/mg/day suppressed platelet function in patients with atrial fibrillation, although it did not affect the increased coagulation activity in these patients. Findings support the premise that anticoagulant therapy is more appropriate than aspirin for the prevention of systemic embolism in patients with atrial fibrillation.
每天服用330毫克阿司匹林可抑制房颤患者的血小板功能，不过它并未影响这些患者增强的凝血活性。这些研究结果支持了这样一个前提，即对于预防房颤患者的全身性栓塞，抗凝治疗比阿司匹林更合适。
